Twenty-two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for Parkinson's disease

被引：3
|
作者：
Charles, Julie [1 ]
Templier, Isabelle [1 ]
Leroux, Dominique [3 ]
Salameire, Dimitri [4 ]
Robert, Caroline [5 ]
Lantuejoul, Sylvie [2 ,4 ]
Leccia, Marie-Therese [1 ]
机构：
[1] CHU Albert Michallon, Clin Univ Dermatovenereol Photobiol & Allergol, Grenoble, France
[2] INSERM, U823, Bases Mol Progress Canc Poumon, La Tronche, France
[3] CHU Albert Michallon, Genet Clin, Dept Genet & Procreat, Grenoble, France
[4] CHU Albert Michallon, Dept Anatomocytopathol, Grenoble, France
[5] Inst Gustave Roussy, Serv Dermatol, F-94805 Villejuif, France
来源：
PIGMENT CELL & MELANOMA RESEARCH | 2009年 / 22卷 / 06期
关键词：
D O I：
10.1111/j.1755-148X.2009.00624.x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：851 / 853
页数：3
相关论文
共 27 条
  • [21] Effects of rehabilitation on reducing dyskinesias in a Parkinson's disease patient abusing therapy with levodopa-carbidopa intestinal gel: a paradigmatic case report and literature review
    Petraroli, A.
    de Sire, A.
    Pino, I
    Moggio, L.
    Marinaro, C.
    Demeco, A.
    Ammendolia, A.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (04): : 1323 - 1329
  • [22] Potential Psychosis Induced by a Sustained High Plasma Levodopa Concentration Due to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson's Disease: A Case Report
    Tezuka, Toshiki
    Nukariya, Tomonori
    Kizuka, Yuta
    Okusa, Shohei
    Okochi, Ryotaro
    Sakai, Yuto
    Nihei, Yoshihiro
    Nakahara, Jin
    Seki, Morinobu
    JOURNAL OF MOVEMENT DISORDERS, 2024, 17 (04) : 453 - 455
  • [23] High dose therapy of a patient with Parkinson's disease with the novel dopamine agonist Pramipexole allows reduction of L-dopa down to nil
    Arnold, G
    Kupsch, A
    NERVENARZT, 1999, 70 (08): : 742 - 744
  • [24] Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies
    Ferreira, Joaquim J.
    Lee, Jee-Young
    Ma, Hyeo-il
    Jeon, Beomseok
    Poewe, Werner
    Antonini, Angelo
    Stocchi, Fabrizio
    Rodrigues, Daniela M.
    Fonseca, Miguel M.
    Castilla-Fernandez, Guillermo
    Holenz, Joerg
    Rocha, Jose-Francisco
    Rascol, Olivier
    JOURNAL OF NEUROLOGY, 2024, 271 (10) : 6729 - 6738
  • [25] Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn's Disease After Helicobacter pylori Quadruple Therapy and Vedolizumab
    Schreidah, Celine M. M.
    Fahmy, Lauren M. M.
    Lapolla, Brigit A. A.
    Kwinta, Bradley D. D.
    Magro, Cynthia M. M.
    Geskin, Larisa J. J.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2023, 45 (08) : 572 - 576
  • [26] Real-World Multicenter Analysis of Levodopa Equivalent Daily Dosage Algorithms- Capturing Geographical and Demographic Disparities in Parkinson's disease (PD) Therapy Spanning Six Countries and Two Continents
    Kukkle, P.
    Kalia, L.
    Habib, A.
    Jagota, P.
    Ojha, R.
    Kandadai, R.
    Desai, S.
    Caldera, M.
    Sirisena, D.
    Garg, D.
    Mestre, T.
    Neupane, R.
    Maytharakcheep, S.
    Sanyawut, K.
    Borgohain, R.
    MOVEMENT DISORDERS, 2024, 39 : S378 - S379
  • [27] Decision-making and duration to accept device-aided therapy in advanced Parkinson's disease Retrospective data from a Central European center with high patient turnover
    Szasz Jozsef Attila
    Szatmari Szabolcs
    Constantin Viorelia
    Mihaly Istvan
    Racz Attila
    Frigy Attila
    Nagy Elod
    Kelemen Krisztina
    Forro Timea
    Almasy Emoke
    Orban-Kis Karoly
    ORVOSI HETILAP, 2021, 162 (21) : 839 - 847
123